According to the Zhitong Finance App, China Resources Pharmaceutical (03320) announced China Resources 39's results for the first nine months of 2026. The total operating revenue was about 21.41 billion yuan, a decrease of 2.62% year on year; net profit was about 2,601 billion yuan, a decrease of 10.28% year on year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.